adult immunization indian guidelines , indication, contradiction , dose and intervals for vaccination
Reading File
Finding Sources
Searching the Web
Indian adult immunization guidelines schedule 2024 API IMA vaccines indication contraindication dose interval
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC4928530
Reading File
Reading File
Searching PubMed
adult immunization schedule India
Adult Immunization Guidelines - India: Indications, Contraindications, Doses & Intervals
Indian adult immunization recommendations are largely based on the API (Association of Physicians of India) / Advisory Committee on Immunization Practices - India guidance (JAPI, "Guidelines for vaccination in normal adults in India"), adapted from ACIP/CDC schedules to Indian epidemiology and vaccine availability. Below is a vaccine-by-vaccine reference.
1. Tetanus, Diphtheria, Pertussis (Td/Tdap)
| Indication | All adults, universal. Especially pregnant women, healthcare workers, wound management |
| Primary series (unvaccinated) | 3 doses of Td: dose 1, dose 2 at least 4 weeks after dose 1, dose 3 given 6-12 months after dose 2. Tdap can substitute for any one Td dose (preferably dose 1) |
| Booster (already immunized) | Substitute one dose of Tdap for the Td booster, then Td every 10 years for life |
| Contraindication | Severe allergic reaction (anaphylaxis) to vaccine/component; encephalopathy within 7 days of a prior pertussis-containing vaccine (for pertussis component) |
| Precaution | Guillain-Barre syndrome within 6 weeks of prior tetanus vaccine; moderate-severe acute illness |
2. Pneumococcal (PCV13/PCV15/PCV20 and PPSV23)
| Indication | Adults ≥65 years; adults 19-64 with chronic heart/lung/liver/renal disease, diabetes, alcoholism, smoking, asplenia, CSF leak, cochlear implant, immunocompromise (HIV, malignancy, transplant) |
| Dose/Interval | If unvaccinated: PCV13 (or PCV15/20) first, followed by PPSV23 at a minimum interval of 8 weeks. If PPSV23 given first, PCV can follow after 1 year. Single dose PPSV23 is adequate in most immunocompetent adults with no prior vaccination |
| Revaccination | Repeat PPSV23 only after ≥5 years from first dose (revaccination within 5 years causes hyporesponsiveness) |
| Contraindication | Severe allergic reaction to vaccine components |
| Note | Prevaccination antibody screening is not cost-effective in the Indian population |
3. Influenza
| Indication | Annual vaccination recommended for all adults, particularly ≥50 years, pregnant women, healthcare workers, chronic cardiopulmonary/renal/hepatic disease, diabetes, immunosuppression |
| Dose | 0.5 mL IM, single dose, annually (timed before monsoon/winter peak season in India, though seasonality is regionally variable) |
| Contraindication | Severe allergic reaction to vaccine or egg-based components (for egg-based formulations); Guillain-Barre syndrome within 6 weeks of a previous dose (precaution) |
| Precaution | Moderate-severe acute febrile illness |
4. Hepatitis A
| Indication | Adults without prior HAV immunity in high-risk groups: chronic liver disease, travelers to endemic/low-hygiene areas, food handlers, healthcare/lab workers, MSM, close contacts of adoptees from endemic regions |
| Dose/Interval | 2 doses, IM (deltoid): 0 and 6-12 months (Havrix-type) or 0 and 6-18 months (Vaqta-type); combined HepA-HepB (Twinrix): 0, 1, 6 months (3 doses) |
| Contraindication | Severe allergic reaction to a prior dose or component |
5. Hepatitis B
| Indication | All unvaccinated/non-immune adults, especially healthcare workers, dialysis patients, multiple sexual partners, injection drug users, household/sexual contacts of HBsAg-positive persons, diabetics <60 years |
| Dose/Interval | 3 doses IM at 0, 1, and 6 months (standard schedule); accelerated schedules (0,1,2,12 months) exist for rapid protection needs |
| Contraindication | Severe allergic reaction to yeast or vaccine component |
6. MMR (Measles, Mumps, Rubella)
| Indication | Adults born after 1957 without documented immunity/vaccination, especially women of childbearing age (rubella protection), healthcare workers, students |
| Dose/Interval | 1-2 doses, 0.5 mL SC, at least 4 weeks apart if 2 doses needed |
| Contraindication | Pregnancy; immunocompromised states; severe allergic reaction to vaccine/component (gelatin, neomycin) |
| Precaution | Give at least 4 weeks before or 3 months after immunoglobulin/blood product administration |
7. Varicella
| Indication | Adults with no history of chickenpox/vaccination/serologic immunity, especially healthcare workers, household contacts of immunocompromised individuals |
| Dose/Interval | 2 doses SC, 4-8 weeks apart |
| Contraindication | Pregnancy; immunocompromised states (live vaccine); severe allergic reaction to gelatin/neomycin |
8. HPV (Human Papillomavirus)
| Indication | Females (and males, per updated guidance) 9-26 years routinely; can be considered up to 45 years on shared decision-making basis |
| Dose/Interval | Age 9-14 years: 2 doses at 0 and 6 months. Age ≥15 years: 3 doses at 0, 1-2, and 6 months |
| Contraindication | Pregnancy; severe allergic reaction to yeast/component |
9. Typhoid (relevant for Indian context - endemic)
| Indication | Adults in endemic areas, food handlers, travelers, outbreak settings |
| Dose/Interval | Vi polysaccharide vaccine: single 0.5 mL IM dose, revaccination every 2-3 years if ongoing risk; Typhoid conjugate vaccine (TCV) increasingly preferred |
| Contraindication | Severe allergic reaction to prior dose |
10. Rabies (pre-exposure, for high-risk adults)
| Indication | Veterinarians, animal handlers, lab workers with rabies virus exposure, travelers to high-endemicity rural areas |
| Dose/Interval | Pre-exposure: 3 doses IM/ID on days 0, 7, 21 or 28 |
| Contraindication | Severe allergic reaction to a previous dose (post-exposure prophylaxis has no absolute contraindication given fatality of untreated rabies) |
11. Herpes Zoster
| Indication | Adults ≥50 years (recombinant zoster vaccine) or ≥60 years (live zoster vaccine, where used), immunocompromised adults with recombinant vaccine |
| Dose/Interval | Recombinant (Shingrix-type): 2 doses IM, 2-6 months apart |
| Contraindication | Severe allergic reaction to component; pregnancy (for live vaccine) |
12. Meningococcal
| Indication | Asplenia/complement deficiency, HIV, travel to meningitis belt (sub-Saharan Africa) or Hajj pilgrims (mandatory for Saudi Arabia visa), military recruits, lab workers |
| Dose/Interval | 1-2 doses depending on vaccine and risk category; booster every 5 years if risk persists |
| Contraindication | Severe allergic reaction to vaccine component |
13. COVID-19 (still relevant for high-risk adults in India)
| Indication | Elderly, comorbid, immunocompromised adults per current national guidance; booster doses per government rollout |
| Dose/Interval | As per current national schedule; intervals typically 6-12 months for booster in high-risk groups |
| Contraindication | Severe allergic reaction/anaphylaxis to a previous dose or vaccine component |
General Principles for Interrupted Schedules
If a series is interrupted after the first dose, the second dose should be given as soon as possible, with subsequent doses separated by the minimum intervals (do not restart the series). If only the final dose is delayed, give it as soon as feasible without repeating earlier doses (Guidelines for vaccination in normal adults in India, JAPI).
General Contraindications Across Most Vaccines
- Anaphylaxis/severe allergic reaction to a previous dose or vaccine component
- Live vaccines (MMR, varicella, live-attenuated influenza, oral typhoid, yellow fever): avoid in pregnancy and significant immunosuppression
- Moderate-severe acute illness is a precaution (defer, not an absolute contraindication)
A relevant note: a recent Indian systematic review and meta-analysis on COVID-19 vaccine hesitancy in India (PMID: 39670935) highlights that hesitancy remains a barrier to adult uptake, which is useful context if you're working on implementation rather than just the clinical schedule.
Sources: Guidelines for vaccination in normal adults in India (JAPI/API adult immunization guidelines); - Textbook of Family Medicine 9e, p. 131; - The Washington Manual of Medical Therapeutics, Appendix (Adult Immunization Table), p. 1107.
If you want, I can go deeper into any single vaccine (e.g., full special-population adjustments for pregnancy, HIV, renal failure, or healthcare workers) or produce this as a downloadable chart/PDF.
This is a shared conversation. Sign in to Orris to start your own chat.